US Stock MarketDetailed Quotes

EVAX Evaxion Biotech

Watchlist
  • 2.988
  • +0.078+2.68%
Close Jul 26 16:00 ET
  • 2.988
  • 0.0000.00%
Post 20:01 ET
16.17MMarket Cap-553P/E (TTM)

Evaxion Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
51K
73K
73K
0
0
0
0
0
0
0
Operating revenue
--51K
--73K
--73K
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-29.46%4.45M
-11.85%22.27M
-32.00%4.44M
-5.28%5.76M
-9.30%5.68M
-1.48%6.3M
-2.21%25.26M
-15.49%6.53M
2.89%6.08M
-10.92%6.26M
Selling and administrative expenses
-34.30%1.61M
24.99%10.08M
-19.24%1.86M
45.51%2.93M
27.67%2.74M
53.73%2.45M
30.49%8.06M
54.28%2.31M
34.78%2.02M
12.11%2.15M
-General and administrative expense
-34.30%1.61M
24.99%10.08M
-19.24%1.86M
45.51%2.93M
27.67%2.74M
53.73%2.45M
30.49%8.06M
54.28%2.31M
34.78%2.02M
12.11%2.15M
Research and development costs
-26.38%2.84M
-30.14%11.92M
-43.58%2.3M
-30.43%2.83M
-28.60%2.94M
-19.82%3.85M
-12.90%17.06M
-33.82%4.07M
-7.90%4.07M
-19.55%4.11M
Depreciation amortization depletion
----
90.97%275K
----
----
----
----
102.82%144K
----
----
----
-Depreciation and amortization
----
90.97%275K
----
----
----
----
102.82%144K
----
----
----
Operating profit
30.27%-4.4M
12.14%-22.2M
33.12%-4.36M
5.28%-5.76M
9.30%-5.68M
1.48%-6.3M
2.21%-25.26M
15.49%-6.53M
-2.89%-6.08M
10.92%-6.26M
Net non-operating interest income expense
13,202.44%5.37M
5.35%-743K
86.26%-361K
-165.48%-110K
-117.58%-231K
-111.36%-41K
-393.71%-785K
-331.53%-2.63M
-29.11%168K
384.42%1.31M
Non-operating interest income
1,871.23%5.62M
1,084.62%154K
90.90%-250K
-89.76%72K
-96.95%47K
-45.09%285K
--13K
-112.53%-2.75M
144.10%703K
4,563.64%1.54M
Non-operating interest expense
-24.54%246K
12.41%897K
192.50%111K
-65.98%182K
23.56%278K
106.33%326K
401.89%798K
82.46%-120K
949.02%535K
-54.55%225K
Other net income (expense)
-98.81%25K
64.30%2.11M
Gain on sale of security
----
-98.81%25K
----
----
----
----
64.30%2.11M
----
----
----
Income before tax
115.17%976K
4.29%-22.92M
33.29%-4.7M
0.73%-5.87M
-19.47%-5.91M
-6.58%-6.44M
3.11%-23.94M
0.03%-7.05M
-4.23%-5.92M
33.96%-4.95M
Income tax
-12.37%-218K
-2.33%-790K
-2.31%-177K
-10.86%-194K
-27.12%-225K
21.46%-194K
-333.71%-772K
-113.08%-173K
58.82%-175K
73.54%-177K
Net income
119.13%1.19M
4.51%-22.13M
34.18%-4.52M
1.08%-5.68M
-19.19%-5.68M
-7.77%-6.24M
5.56%-23.17M
17.90%-6.87M
-9.33%-5.74M
30.08%-4.77M
Net income continuous Operations
119.13%1.19M
4.51%-22.13M
34.18%-4.52M
1.08%-5.68M
-19.19%-5.68M
-7.77%-6.24M
5.56%-23.17M
17.90%-6.87M
-9.33%-5.74M
30.08%-4.77M
Minority interest income
Net income attributable to the parent company
119.13%1.19M
4.51%-22.13M
34.18%-4.52M
1.08%-5.68M
-19.19%-5.68M
-7.77%-6.24M
5.56%-23.17M
17.90%-6.87M
-9.33%-5.74M
30.08%-4.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
119.13%1.19M
4.51%-22.13M
34.18%-4.52M
1.08%-5.68M
-19.19%-5.68M
-7.77%-6.24M
5.56%-23.17M
17.90%-6.87M
-9.33%-5.74M
30.08%-4.77M
Basic earnings per share
112.50%0.3
17.35%-8.1
48.28%-1.5
12.50%-2.1
-5.00%-2.1
4.00%-2.4
22.22%-9.8
25.64%-2.9
11.11%-2.4
44.44%-2
Diluted earnings per share
112.50%0.3
17.35%-8.1
48.28%-1.5
12.50%-2.1
-5.00%-2.1
4.00%-2.4
22.22%-9.8
25.64%-2.9
11.11%-2.4
44.44%-2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 51K73K73K0000000
Operating revenue --51K--73K--73K--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -29.46%4.45M-11.85%22.27M-32.00%4.44M-5.28%5.76M-9.30%5.68M-1.48%6.3M-2.21%25.26M-15.49%6.53M2.89%6.08M-10.92%6.26M
Selling and administrative expenses -34.30%1.61M24.99%10.08M-19.24%1.86M45.51%2.93M27.67%2.74M53.73%2.45M30.49%8.06M54.28%2.31M34.78%2.02M12.11%2.15M
-General and administrative expense -34.30%1.61M24.99%10.08M-19.24%1.86M45.51%2.93M27.67%2.74M53.73%2.45M30.49%8.06M54.28%2.31M34.78%2.02M12.11%2.15M
Research and development costs -26.38%2.84M-30.14%11.92M-43.58%2.3M-30.43%2.83M-28.60%2.94M-19.82%3.85M-12.90%17.06M-33.82%4.07M-7.90%4.07M-19.55%4.11M
Depreciation amortization depletion ----90.97%275K----------------102.82%144K------------
-Depreciation and amortization ----90.97%275K----------------102.82%144K------------
Operating profit 30.27%-4.4M12.14%-22.2M33.12%-4.36M5.28%-5.76M9.30%-5.68M1.48%-6.3M2.21%-25.26M15.49%-6.53M-2.89%-6.08M10.92%-6.26M
Net non-operating interest income expense 13,202.44%5.37M5.35%-743K86.26%-361K-165.48%-110K-117.58%-231K-111.36%-41K-393.71%-785K-331.53%-2.63M-29.11%168K384.42%1.31M
Non-operating interest income 1,871.23%5.62M1,084.62%154K90.90%-250K-89.76%72K-96.95%47K-45.09%285K--13K-112.53%-2.75M144.10%703K4,563.64%1.54M
Non-operating interest expense -24.54%246K12.41%897K192.50%111K-65.98%182K23.56%278K106.33%326K401.89%798K82.46%-120K949.02%535K-54.55%225K
Other net income (expense) -98.81%25K64.30%2.11M
Gain on sale of security -----98.81%25K----------------64.30%2.11M------------
Income before tax 115.17%976K4.29%-22.92M33.29%-4.7M0.73%-5.87M-19.47%-5.91M-6.58%-6.44M3.11%-23.94M0.03%-7.05M-4.23%-5.92M33.96%-4.95M
Income tax -12.37%-218K-2.33%-790K-2.31%-177K-10.86%-194K-27.12%-225K21.46%-194K-333.71%-772K-113.08%-173K58.82%-175K73.54%-177K
Net income 119.13%1.19M4.51%-22.13M34.18%-4.52M1.08%-5.68M-19.19%-5.68M-7.77%-6.24M5.56%-23.17M17.90%-6.87M-9.33%-5.74M30.08%-4.77M
Net income continuous Operations 119.13%1.19M4.51%-22.13M34.18%-4.52M1.08%-5.68M-19.19%-5.68M-7.77%-6.24M5.56%-23.17M17.90%-6.87M-9.33%-5.74M30.08%-4.77M
Minority interest income
Net income attributable to the parent company 119.13%1.19M4.51%-22.13M34.18%-4.52M1.08%-5.68M-19.19%-5.68M-7.77%-6.24M5.56%-23.17M17.90%-6.87M-9.33%-5.74M30.08%-4.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 119.13%1.19M4.51%-22.13M34.18%-4.52M1.08%-5.68M-19.19%-5.68M-7.77%-6.24M5.56%-23.17M17.90%-6.87M-9.33%-5.74M30.08%-4.77M
Basic earnings per share 112.50%0.317.35%-8.148.28%-1.512.50%-2.1-5.00%-2.14.00%-2.422.22%-9.825.64%-2.911.11%-2.444.44%-2
Diluted earnings per share 112.50%0.317.35%-8.148.28%-1.512.50%-2.1-5.00%-2.14.00%-2.422.22%-9.825.64%-2.911.11%-2.444.44%-2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg